Adagio Medical Holdings (ADGM) Shares Outstanding (Weighted Average) (2023 - 2026)

Adagio Medical Holdings (ADGM) has 4 years of Shares Outstanding (Weighted Average) data on file, last reported at $22.2 million in Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $22.2 million, up 44.45% year-over-year; the trailing twelve-month figure through Mar 2026 was $22.2 million (up 44.45% YoY), and the FY2025 annual result was $7.5 million, down 49.04% from the prior year.
• Shares Outstanding (Weighted Average) rose to $22.2 million in Q1 2026 per ADGM's latest filing, from $7.5 million in the prior quarter.
• Over five years, Shares Outstanding (Weighted Average) peaked at $22.2 million in Q1 2026 and troughed at $1.0 in Q2 2024.
• A 4-year average of $9.7 million and a median of $14.1 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
• On a YoY basis, Shares Outstanding (Weighted Average) climbed as much as 1537854200.0% in 2025 and fell as far as 49.04% in 2025.
• A 4-year view of Shares Outstanding (Weighted Average) shows it stood at $759814.0 in 2023, then jumped by 1844.25% to $14.8 million in 2024, then plunged by 49.04% to $7.5 million in 2025, then surged by 195.01% to $22.2 million in 2026.
• Business Quant data shows ADGM's Shares Outstanding (Weighted Average) at $22.2 million in Q1 2026, $7.5 million in Q4 2025, and $15.4 million in Q3 2025.